Retatrutide clinical trial

Retatrutide Clinical Trial NCT05929079

The National Library of Medicine is recruiting for clinical trial NCT05929079 – A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2).

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.

Clinical Trial Information ID: NCT05929079
Study Start (Actual): 2023-07-11
Primary Completion (Estimated): 2026-05-03
Study Completion (Estimated): 2026-05-31
Enrollment (Estimated): 1000

Clinical Trial Application Link:

Similar Posts